{"content":"<li class=\"n-box-item date-title\" data-end=\"1517029199\" data-start=\"1516942800\" data-txt=\"Monday, December 23, 2019\">Friday, January 26, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3325892\" data-ts=\"1517011216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASI\" target=\"_blank\">CASI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325892-casi-pharmaceuticals-buys-anda-portfolio-from-sandoz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CASI Pharmaceuticals buys ANDA portfolio from Sandoz</a></h4><ul>   <li>CASI Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a>) has <a href=\"https://seekingalpha.com/pr/17057887-casi-pharmaceuticals-acquires-anda-portfolio-sandoz-inc-sandoz\" target=\"_blank\">acquired a portfolio</a> of abbreviated new drug applications from Sandoz.</li>    <li>The applications include 25 FDA-approved ANDAs, one ANDA that has tentative approval from the FDA, and three that are still pending approval.</li>    <li>CASI says it plans to choose and commercialize some products based on market opportunity and the prospect of cost-effective manufacturing in China and/or the U.S.</li>    <li>Shares are <font color='green'>up 3.1%</font> in postmarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325892\" data-linked=\"CASI Pharmaceuticals buys ANDA portfolio from Sandoz\" data-tweet=\"$CASI - CASI Pharmaceuticals buys ANDA portfolio from Sandoz https://seekingalpha.com/news/3325892-casi-pharmaceuticals-buys-anda-portfolio-from-sandoz?source=tweet\" data-url=\"https://seekingalpha.com/news/3325892-casi-pharmaceuticals-buys-anda-portfolio-from-sandoz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325882\" data-ts=\"1517006154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325882-after-hours-gainers-losers-1-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (1/26/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a> <font color='green'>+1.9%</font>. <a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/GDS' title='GDS Holdings'>GDS</a> <font color='green'>+1.2%</font>. <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+1.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/ROYT' title='Pacific Coast Oil Trust'>ROYT</a> <font color='red'>-10.1%</font>. <a href='https://seekingalpha.com/symbol/SBBX' title='Sussex Bancorp'>SBBX</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/SE' title='Sea Ltd'>SE</a> <font color='red'>-1.7%</font>. <a href='https://seekingalpha.com/symbol/TRN' title='Trinity Industries Inc.'>TRN</a> <font color='red'>-1.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325882\" data-linked=\"After Hours Gainers / Losers (1/26/2018)\" data-tweet=\"$AMRN $SOGO $GDS - After Hours Gainers / Losers (1/26/2018) https://seekingalpha.com/news/3325882-after-hours-gainers-losers-1-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3325882-after-hours-gainers-losers-1-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325878\" data-ts=\"1517004929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325878-weekly-etf-gainers-losers-1-26-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers (1/26/18)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='green'>+7.7%</font>. <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a> <font color='green'>+6.4%</font>. <a href='https://seekingalpha.com/symbol/ILF' title='iShares Latin America 40 ETF'>ILF</a> <font color='green'>+5.6%</font>. <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='green'>+5.5%</font>. <a href='https://seekingalpha.com/symbol/BRF' title='VanEck Vectors Brazil Small-Cap ETF'>BRF</a> <font color='green'>+5.3%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='red'>-1.9%</font>. <a href='https://seekingalpha.com/symbol/TAN' title='Guggenheim Solar ETF'>TAN</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a> <font color='red'>-1.7%</font>. <a href='https://seekingalpha.com/symbol/KBWD' title='PowerShares KBW High Dividend Yield Financial Portfolio ETF'>KBWD</a> <font color='red'>-1.1%</font>. <a href='https://seekingalpha.com/symbol/PGF' title='PowerShares Financial Preferred Portfolio ETF'>PGF</a> <font color='red'>-0.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325878\" data-linked=\"Weekly ETF Gainers / Losers (1/26/18)\" data-tweet=\"$UNG $EWZ $ILF - Weekly ETF Gainers / Losers (1/26/18) https://seekingalpha.com/news/3325878-weekly-etf-gainers-losers-1-26-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3325878-weekly-etf-gainers-losers-1-26-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325876\" data-ts=\"1517004187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325876-momoplus-1_2-jpmorgan-boosts-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momo +1.2% as JPMorgan boosts to Overweight</a></h4><ul>    <li>Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) ADRs are adding to gains today after getting an upgrade to Overweight from JPMorgan.</li>    <li>Shares are <font color='green'>up 1.2%</font> after hours; they <font color='green'>gained 1.8%</font> during the regular session.</li>    <li>Along with the boost from a Neutral stance, JPMorgan has raised its price target to $40 from $30, implying 32% upside from today's close.</li>    <li>The ADRs are <font color='green'>up 34%</font> since the beginning of December.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325876\" data-linked=\"Momo +1.2% as JPMorgan boosts to Overweight\" data-tweet=\"$MOMO - Momo +1.2% as JPMorgan boosts to Overweight https://seekingalpha.com/news/3325876-momoplus-1_2-jpmorgan-boosts-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3325876-momoplus-1_2-jpmorgan-boosts-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325846\" data-ts=\"1517001264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325846-bloodbath-in-mortgage-reits-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloodbath in mortgage REITs continues</a></h4><ul><li>If the story of 2017 was the mREIT (BATS:<a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>) sector nearly-universally trading above book value, the story so far in 2018 is the quick retreat back below book by many of the names, with investors mulling what might be a speedier pace of rate hikes.</li><li>The month isn't over yet, but some January stats: Annaly Capital (NYSE:<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a>)&nbsp;<font color='red'>down 8.25%</font>, AGNC Investment&nbsp;<font color='red'>down 3.3%</font>, CYS Investment (NYSE:<a href='https://seekingalpha.com/symbol/CYS' title='CYS Investments, Inc.'>CYS</a>)&nbsp;<font color='red'>down 10.65%</font>, Armour Residential (NYSE:<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a>)&nbsp;<font color='red'>down 4.6%</font>, Invesco Mortgage (NYSE:<a href='https://seekingalpha.com/symbol/IVR' title='Invesco Mortgage Capital Inc.'>IVR</a>)&nbsp;<font color='red'>down 3.4%</font>, MFA Financial (NYSE:<a href='https://seekingalpha.com/symbol/MFA' title='MFA Financial, Inc.'>MFA</a>)&nbsp;<font color='red'>down 6.2%</font>.</li><li>The S&amp;P 500 is&nbsp;<font color='green'>up 7.3%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3325846\" data-linked=\"Bloodbath in mortgage REITs continues\" data-tweet=\"$NLY $REM $NLY - Bloodbath in mortgage REITs continues https://seekingalpha.com/news/3325846-bloodbath-in-mortgage-reits-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3325846-bloodbath-in-mortgage-reits-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>119&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325840\" data-ts=\"1517000541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXW\" target=\"_blank\">CXW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325840-administration-memo-sends-corecivic-and-geo-group-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Administration memo sends Corecivic and GEO Group higher</a></h4><ul><li><a href=\"https://admin.govexec.com/media/gbc/docs/pdfs_edit/012518privateprisons.pdf\" target=\"_blank\">A DOJ memo </a>dated Wednesday suggests boosting the amount of inmates in private prisons.</li><li>Both previously down for the day, Corecivic (<a href='https://seekingalpha.com/symbol/CXW' title='CoreCivic, Inc.'>CXW</a> <font color='green'>+5.6%</font>) and GEO Group (<a href='https://seekingalpha.com/symbol/GEO' title='The GEO Group, Inc.'>GEO</a> <font color='green'>+3%</font>) have both moved sharply higher late in the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325840\" data-linked=\"Administration memo sends Corecivic and GEO Group higher\" data-tweet=\"$CXW $CXW $GEO - Administration memo sends Corecivic and GEO Group higher https://seekingalpha.com/news/3325840-administration-memo-sends-corecivic-and-geo-group-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3325840-administration-memo-sends-corecivic-and-geo-group-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325836\" data-ts=\"1517000255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PF\" target=\"_blank\">PF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325836-pinnacle-foods-races-higher-on-report-of-third-point-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinnacle Foods races higher on report of Third Point stake</a></h4><ul><li>A modestly red day for Pinnacle Foods (<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a> <font color='green'>+4.3%</font>) has turned sharply into the green in the past few minutes, with Reuters reporting Dan Loeb's hedge fund as having built a stake.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325836\" data-linked=\"Pinnacle Foods races higher on report of Third Point stake\" data-tweet=\"$PF - Pinnacle Foods races higher on report of Third Point stake https://seekingalpha.com/news/3325836-pinnacle-foods-races-higher-on-report-of-third-point-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3325836-pinnacle-foods-races-higher-on-report-of-third-point-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325835\" data-ts=\"1517000110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325835-wynn-defended-morgan-stanley-shares-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn defended at Morgan Stanley; shares down 10%</a></h4><ul><li>via Bloomberg</li><li>If the stock gets weak enough, says the team, Wynn (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='red'>-10.4%</font>) might begin to look pretty attractive as a takeover target.</li><li>As to the charges themselves, they're concerning, but also maybe old news, says Morgan, noting allegations in a Bloomberg story from late last year.</li><li>While Steve Wynn is the company's driving force, there is an ample bench of executives.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325782-steve-wynn-hit-sexual-misconduct-report-shares-dive-5-percent\" target=\"_blank\">Steve Wynn hit with sexual misconduct report; shares dive more than 5%</a> (Jan. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325835\" data-linked=\"Wynn defended at Morgan Stanley; shares down 10%\" data-tweet=\"$WYNN - Wynn defended at Morgan Stanley; shares down 10% https://seekingalpha.com/news/3325835-wynn-defended-morgan-stanley-shares-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3325835-wynn-defended-morgan-stanley-shares-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325829\" data-ts=\"1516998480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPAH\" target=\"_blank\">CPAH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325829-counterpath-closes-private-placement-of-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CounterPath closes private placement of shares</a></h4><ul>   <li>CounterPath (<a href=\"http://seekingalpha.com/symbol/CPAH\" target=\"_blank\">CPAH</a> <font color='red'>-6%</font>) has filed that it <a href=\"https://seekingalpha.com/filing/3845786\" target=\"_blank\">closed a private placement</a> of 427,500 shares.</li>    <li>That placement came at a price of $4.01/share</li>    <li>Gross proceeds were $1.714M. Net proceeds will be used, the company says, to expand sales and business development resources and fund integration of the Company&rsquo;s UC solutions with other enterprise applications, along with general purposes.</li>    <li>The company's largest shareholder, Wesley Clover International, along with No. 2 holder KMB Trac Two Holdings, subscribed for an 125,000 shares each.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325829\" data-linked=\"CounterPath closes private placement of shares\" data-tweet=\"$CPAH - CounterPath closes private placement of shares https://seekingalpha.com/news/3325829-counterpath-closes-private-placement-of-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3325829-counterpath-closes-private-placement-of-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325827\" data-ts=\"1516997854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POL\" target=\"_blank\">POL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325827-polyoneminus-4-raw-material-costs-may-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolyOne -4% as raw material costs may increase further</a></h4><ul>     <li>PolyOne (<a href='https://seekingalpha.com/symbol/POL' title='PolyOne Corporation'>POL</a> <font color='red'>-3.9%</font>) plunges to a 52-week low after saying its raw material costs could rise further in Q1 and that it does not expect Y/Y income and margin growth in its Specialty Engineered Materials unit until H2 2018.</li>     <li>In its <a href=\"https://seekingalpha.com/news/3325631-polyone-beats-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a> report, POL said continued raw material inflation and supply-chain disruptions hurt margins in every business; the company's material costs on average rose 10% Q/Q and 15%-20% Y/Y.</li>     <li>POL said in its earnings conference call that 2017 was \"a difficult year for Engineered Materials and the industry as a whole\" due to raw material pricing pressures, but it expects cash flow to improve in 2018, reflecting underlying earnings improvements, savings from new and ongoing projects, and benefits from lower U.S. tax rates.</li>     <li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325827\" data-linked=\"PolyOne -4% as raw material costs may increase further\" data-tweet=\"$POL - PolyOne -4% as raw material costs may increase further https://seekingalpha.com/news/3325827-polyoneminus-4-raw-material-costs-may-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3325827-polyoneminus-4-raw-material-costs-may-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325826\" data-ts=\"1516997553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325826-citron-on-twitter-train-amid-deal-chatter-shares-up-9_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron on Twitter train amid deal chatter; shares up 9.3%</a></h4><ul>   <li>Already up strong on the day, Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) shares are <font color='green'>up 9.3%</font> and re-nearing a 52-week high hit two weeks ago with deal rumors circulating, and noted short seller Citron Research issuing praise.</li>    <li>Unsupported chatter about a potential buyout by Salesforce.com (<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a> <font color='green'>+1.3%</font>) is fueling some of the buying, Bloomberg notes. Call volume on TWTR is outpacing put volume by a factor of eight today.</li>    <li>Meanwhile, Citron says it gets a lot of emails about what it might be buying in this market. \"Have been long $TWTR and agree with Hedgeye and Greenlight that <a href=\"https://twitter.com/CitronResearch/status/956943859216351232\" target=\"_blank\">2018 is the year for $TWTR,</a>\" the firm tweets.</li>    <li>\"Target $35, Think Tencent buys,\" Citron continues. \"Now go bash Citron on $TWTR.\" A $35 target implies another 44% upside from today's sharply higher price.</li><li>Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a>) is <font color='green'>up 2.8%</font> on the day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325826\" data-linked=\"Citron on Twitter train amid deal chatter; shares up 9.3%\" data-tweet=\"$TWTR $TWTR $CRM - Citron on Twitter train amid deal chatter; shares up 9.3% https://seekingalpha.com/news/3325826-citron-on-twitter-train-amid-deal-chatter-shares-up-9_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3325826-citron-on-twitter-train-amid-deal-chatter-shares-up-9_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325823\" data-ts=\"1516996886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325823-semiconductors-finish-week-strong-on-intel-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semiconductors finish week strong on Intel earnings</a></h4><ul><li>        Semiconductors showing strength in the final stretch of the week with the Philadelphia Semiconductor Index&nbsp;<font color='green'>up 2.6%</font>&nbsp;today.</li><li>               Semi-related stocks that reported earnings this week: Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+9.6%</font>), KLA-Tencor (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='red'>-0.4%</font>), Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='green'>+1.1%</font>), Maxim Integrated Products (<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a> <font color='green'>+5.8%</font>), Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a> <font color='green'>+5.3%</font>), and Xilinx (<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color='green'>+2%</font>).&nbsp;</li><li>               Other semi stocks that have been on the move:&nbsp; ON Semiconductors (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='green'>+4.2%</font>), ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color='green'>+2.7%</font>), Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+0.6%</font>), Analog Devices (<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a> <font color='green'>+1.6%</font>), and Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='green'>+1%</font>).&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Semi ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3325023-lam-research-plus-3_4-percent-q2-beats-upside-guidance\" target=\"_blank\">Lam Research +3.4% on Q2 beats, upside guidance</a> (Jan. 24)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325077-teradyne-minus-6-percent-despite-q4-beats-line-guidance\" target=\"_blank\">Teradyne -6% despite Q4 beats, in-line guidance</a> (Jan. 24)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325784-maxim-integrated-products-plus-5_2-percent-q2-report-upside-guidance\" target=\"_blank\">Maxim Integrated Products +5.2% after Q2 report, upside guidance</a> (Jan. 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325052-xilinx-plus-4_5-percent-q3-revenue-beat-ninth-consecutive-quarter-rev-growth\" target=\"_blank\">Xilinx +4.5% after Q3 revenue beat, ninth consecutive quarter rev growth</a> (Jan. 24)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325654-kla-tencor-minus-1_1-percent-q2-report-downside-guidance\" target=\"_blank\">KLA-Tencor -1.1% after Q2 report with downside guidance</a> (Jan. 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325519-intel-plus-4_5-percent-q4-beats-data-center-growth-upside-guidance\" target=\"_blank\">Intel +4.5% on Q4 beats, data center growth, upside guidance</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325823\" data-linked=\"Semiconductors finish week strong on Intel earnings\" data-tweet=\"$INTC $INTC $KLAC - Semiconductors finish week strong on Intel earnings https://seekingalpha.com/news/3325823-semiconductors-finish-week-strong-on-intel-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3325823-semiconductors-finish-week-strong-on-intel-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325821\" data-ts=\"1516996522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325821-technology-top-gainers-losers-of-2_55-pm-1-26-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (1/26/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/RPD' title='Rapid7'>RPD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NSYS' title='Nortech Systems Incorporated'>NSYS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/EGHT' title='8X8 Inc'>EGHT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='red'>-7%</font>. DVMT <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325821\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (1/26/18)\" data-tweet=\"$MYSZ $RPD $NSYS - Technology - Top Gainers / Losers as of 2.55 pm (1/26/18) https://seekingalpha.com/news/3325821-technology-top-gainers-losers-of-2_55-pm-1-26-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3325821-technology-top-gainers-losers-of-2_55-pm-1-26-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325818\" data-ts=\"1516995909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRC\" target=\"_blank\">HRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325818-needham-hill-rom-ceo-exit-loss-shares-down-3_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham: Hill-Rom CEO exit a &#39;loss&#39; - shares down 3.4%</a></h4><ul><li>CEO John Greisch's surprise departure is a loss, says analyst Mike Matson, thanks to his strong track record and investor relationships.</li><li>Turning to FQ1 results, Matson takes note of slowing organic growth, but - believing new products will drive more revenue - boosts his FY18 EPS estimate to $4.62 from $4.59 and FY19 to $5.14 from $5.11.</li><li>He maintains a Buy rating and $105 price target (nearly&nbsp;<font color='green'>20% upside</font>).</li><li>Source: Bloomberg</li><li><a href='https://seekingalpha.com/symbol/HRC' title='Hill-Rom Holdings, Inc.'>HRC</a>&nbsp;<font color='red'>-3.4%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3325647-hill-rom-chief-retire-q3\" target=\"_blank\">Hill-Rom chief to retire in Q3</a> (Jan. 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325645-hill-rom-holdings-q1-revenues-5-percent-non-gaap-eps-23-percent-updates-guidance\" target=\"_blank\">Hill-Rom Holdings Q1 revenues up 5%; non-GAAP EPS up 23%; updates guidance</a> (Jan. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325818\" data-linked=\"Needham: Hill-Rom CEO exit a &#39;loss&#39; - shares down 3.4%\" data-tweet=\"$HRC - Needham: Hill-Rom CEO exit a &#39;loss&#39; - shares down 3.4% https://seekingalpha.com/news/3325818-needham-hill-rom-ceo-exit-loss-shares-down-3_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3325818-needham-hill-rom-ceo-exit-loss-shares-down-3_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325817\" data-ts=\"1516995815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IP\" target=\"_blank\">IP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325817-international-paper-higher-on-report-of-price-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Paper higher on report of price hike</a></h4><ul><li>International Paper (NYSE:<a href='https://seekingalpha.com/symbol/IP' title='International Paper Co.'>IP</a>) is higher on reports the company hiked its containerboard pricing by $50 per ton.</li><li>Shares of International Paper are&nbsp;<font color='green'>up 2.0%</font>&nbsp;in afternoon trading.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325817\" data-linked=\"International Paper higher on report of price hike\" data-tweet=\"$IP - International Paper higher on report of price hike https://seekingalpha.com/news/3325817-international-paper-higher-on-report-of-price-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3325817-international-paper-higher-on-report-of-price-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325814\" data-ts=\"1516993706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITK\" target=\"_blank\">MITK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325814-mitek-systemsminus-5_3-after-q1-beats-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mitek Systems -5.3% after Q1 beats, in-line guidance</a></h4><ul><li>        Mitek Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems Inc.'>MITK</a>) shares are&nbsp;<font color='red'>down 5.3%</font>&nbsp;following yesterday&rsquo;s Q1 report, which beat EPS and revenue estimates.</li><li>               In-line FY18 guidance has revenue from $57M to $59M ($58.04M) and profit margin of 19% to 20%. &nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17057052-mitek-reports-31-percent-revenue-growth-first-quarter-fiscal-2018\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325470-mitek-systems-beats-0_01-beats-revenue\" target=\"_blank\">Mitek Systems beats by $0.01, beats on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325814\" data-linked=\"Mitek Systems -5.3% after Q1 beats, in-line guidance\" data-tweet=\"$MITK - Mitek Systems -5.3% after Q1 beats, in-line guidance https://seekingalpha.com/news/3325814-mitek-systemsminus-5_3-after-q1-beats-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325814-mitek-systemsminus-5_3-after-q1-beats-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325812\" data-ts=\"1516993267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325812-energy-materials-top-gainers-losers-of-2-00-pm-1-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (1/26/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325812\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (1/26/2018)\" data-tweet=\"$RKDA $CRK $GSV - Energy/Materials - Top Gainers / Losers as of 2:00 pm (1/26/2018) https://seekingalpha.com/news/3325812-energy-materials-top-gainers-losers-of-2-00-pm-1-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3325812-energy-materials-top-gainers-losers-of-2-00-pm-1-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325809\" data-ts=\"1516993206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSIT\" target=\"_blank\">GSIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325809-gsi-technologyminus-5_4-after-q3-results-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSI Technology -5.4% after Q3 results with downside guidance</a></h4><ul><li>        GSI Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/GSIT' title='GSI Technology, Inc.'>GSIT</a>) shares are&nbsp;<font color='red'>down 5.4%&nbsp;</font>following yesterday&rsquo;s Q3 report, which beat revenue estimates but missed on EPS.</li><li>               Downside guidance for Q4 includes revenue of $10M to $11M (consensus: $12.5M) and gross margin from 53% to 55%.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17057042-gsi-technology-inc-reports-third-quarter-fiscal-2018-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325468-gsi-technology-misses-0_03-beats-revenue\" target=\"_blank\">GSI Technology misses by $0.03, beats on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325809\" data-linked=\"GSI Technology -5.4% after Q3 results with downside guidance\" data-tweet=\"$GSIT - GSI Technology -5.4% after Q3 results with downside guidance https://seekingalpha.com/news/3325809-gsi-technologyminus-5_4-after-q3-results-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325809-gsi-technologyminus-5_4-after-q3-results-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325803\" data-ts=\"1516991339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXGN\" target=\"_blank\">NXGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325803-quality-systemsminus-1_7-on-q3-report-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quality Systems -1.7% on Q3 report with in-line guidance</a></h4><ul><li>        Quality Systems (QSII) shares are&nbsp;<font color='red'>down 1.7%</font>&nbsp;after yesterday&rsquo;s Q3 report beat revenue estimates but met on EPS.</li><li>               Reaffirmed in-line FY18 guidance has revenue of $522M to $530M (consensus: $526.54M) and EPS from $0.64 to $0.68 (consensus: $0.68). &nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17057084-quality-systems-inc-reports-fiscal-2018-third-quarter-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325478-quality-systems-eps-line-beats-revenue\" target=\"_blank\">Quality Systems EPS in-line, beats on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325803\" data-linked=\"Quality Systems -1.7% on Q3 report with in-line guidance\" data-tweet=\"$NXGN - Quality Systems -1.7% on Q3 report with in-line guidance https://seekingalpha.com/news/3325803-quality-systemsminus-1_7-on-q3-report-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325803-quality-systemsminus-1_7-on-q3-report-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325797\" data-ts=\"1516989893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325797-big-biopharma-in-green-after-abbvies-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big biopharma in the green after AbbVie&#39;s Q4 beat</a></h4><ul><li>AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+10.6%</font>) is leading its large-cap brethren after posting steller Q4 results and bullish 2018 guidance.</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='green'>+0.2%</font>)(<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='green'>+0.2%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+1.3%</font>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='green'>+1%</font>)(<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='green'>+1.4%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+4.4%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+2.3%</font>)(VRX <font color='red'>-1.8%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325677-abbvie-q4-revenues-14-percent-non-gaap-eps-23-percent-updates-guidance\" target=\"_blank\">AbbVie Q4 revenues up 14%; non-GAAP EPS up 23%; updates guidance</a> (Jan. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325797\" data-linked=\"Big biopharma in the green after AbbVie&#39;s Q4 beat\" data-tweet=\"$ABBV $ABBV $JNJ - Big biopharma in the green after AbbVie&#39;s Q4 beat https://seekingalpha.com/news/3325797-big-biopharma-in-green-after-abbvies-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3325797-big-biopharma-in-green-after-abbvies-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325796\" data-ts=\"1516989661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBH\" target=\"_blank\">SBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325796-sally-beauty-holdings-swings-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sally Beauty Holdings swings lower</a></h4><ul> <li>Sally Beauty Holdings (<a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a> <font color='red'>-2.6%</font>) heads lower after data tracker M Science posts a negative assessment on the retailer's sales growth.</li><li>Sally Beauty is due to report earnings on February 8.</li> <li>Shares of SBH were down as much as 5% earlier.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3325796\" data-linked=\"Sally Beauty Holdings swings lower\" data-tweet=\"$SBH - Sally Beauty Holdings swings lower https://seekingalpha.com/news/3325796-sally-beauty-holdings-swings-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3325796-sally-beauty-holdings-swings-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325794\" data-ts=\"1516989652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325794-financial-top-gainers-losers-of-1-00-pm-1-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financial - Top Gainers / Losers as of 1:00 pm (1/26/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WRLD' title='World Acceptance Corporation'>WRLD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/AJG' title='Arthur J.Gallagher & Co.'>AJG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TBBK' title='The Bancorp, Inc.'>TBBK</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AHL' title='Aspen Insurance Holdings Limited'>AHL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DCOM' title='Dime Community Bancshares, Inc.'>DCOM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FHB' title='First Hawaiian'>FHB</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/FSBW' title='FS Bancorp'>FSBW</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325794\" data-linked=\"Financial - Top Gainers / Losers as of 1:00 pm (1/26/2018)\" data-tweet=\"$WRLD $LMFA $GROW - Financial - Top Gainers / Losers as of 1:00 pm (1/26/2018) https://seekingalpha.com/news/3325794-financial-top-gainers-losers-of-1-00-pm-1-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3325794-financial-top-gainers-losers-of-1-00-pm-1-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325788\" data-ts=\"1516988410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325788-midday-gainers-losers-1-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (1/26/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+66%</font>. <a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ABAX' title='ABAXIS, Inc.'>ABAX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/WRLD' title='World Acceptance Corporation'>WRLD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma'>FWP</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TBBK' title='The Bancorp, Inc.'>TBBK</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AHL' title='Aspen Insurance Holdings Limited'>AHL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PATK' title='Patrick Industries, Inc.'>PATK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325788\" data-linked=\"Midday Gainers / Losers (1/26/2018)\" data-tweet=\"$BSPM $OASM $CAPR - Midday Gainers / Losers (1/26/2018) https://seekingalpha.com/news/3325788-midday-gainers-losers-1-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3325788-midday-gainers-losers-1-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325784\" data-ts=\"1516987544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXIM\" target=\"_blank\">MXIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325784-maxim-integrated-productsplus-5_2-after-q2-report-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim Integrated Products +5.2% after Q2 report, upside guidance</a></h4><ul><li>        Maxim Integrated Products (NASDAQ:<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a>) shares are&nbsp;<font color='green'>up 5.2%&nbsp;</font>following yesterday&rsquo;s Q2 report that beat on revenue and met on EPS.</li><li>               Upside Q3 guidance has revenue from $620M to $660M (consensus: $602.21M), EPS of $0.66 to $0.72 (consensus: $0.63), and gross margin from 66% to 68%.&nbsp;</li><li>               Guidance is based on the $446M 90-day backlog at the beginning of the March quarter and the expected turns.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17057040-maxim-integrated-reports-results-second-quarter-fiscal-2018-increases-dividend-17-percent\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325464-maxim-integrated-products-eps-line-beats-revenue\" target=\"_blank\">Maxim Integrated Products EPS in-line, beats on revenue</a> (Jan. 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325492-maxim-integrated-products-declares-0_42-dividend\" target=\"_blank\">Maxim Integrated Products declares $0.42 dividend</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325784\" data-linked=\"Maxim Integrated Products +5.2% after Q2 report, upside guidance\" data-tweet=\"$MXIM - Maxim Integrated Products +5.2% after Q2 report, upside guidance https://seekingalpha.com/news/3325784-maxim-integrated-productsplus-5_2-after-q2-report-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325784-maxim-integrated-productsplus-5_2-after-q2-report-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325782\" data-ts=\"1516987083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325782-steve-wynn-hit-sexual-misconduct-report-shares-dive-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steve Wynn hit with sexual misconduct report; shares dive more than 5%</a></h4><ul><li><a href=\"https://www.wsj.com/articles/dozens-of-people-recount-pattern-of-sexual-misconduct-by-las-vegas-mogul-steve-wynn-1516985953?tesla=y&amp;mod=e2tw\" target=\"_blank\">A <em>WSJ</em> report</a> alleges a decades-long pattern of sexual misconduct by Steve Wynn.</li><li>Responding, Wynn says the accusations come about thanks to his ex-wife, with whom he is involved in a legal battle over a revised divorce settlement.</li><li><a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>&nbsp;<font color='red'>-5.25%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3325782\" data-linked=\"Steve Wynn hit with sexual misconduct report; shares dive more than 5%\" data-tweet=\"$WYNN - Steve Wynn hit with sexual misconduct report; shares dive more than 5% https://seekingalpha.com/news/3325782-steve-wynn-hit-sexual-misconduct-report-shares-dive-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3325782-steve-wynn-hit-sexual-misconduct-report-shares-dive-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>101&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325778\" data-ts=\"1516986208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325778-analyst-adjust-western-digital-ratings-price-targets-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst adjust Western Digital ratings, price targets after earnings</a></h4><ul><li>        Summit Redstone downgrades Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) from Buy to Hold following yesterday&rsquo;s earnings report.</li><li>               Analyst Kinngai Chan cites &ldquo;high risk of gross margin compression given recent pricing dynamics in NAND flash and client SSD markets.\"&nbsp;</li><li>               Chan says recent checks show the recent NAND/SSD price declines to continue into the end of the month.&nbsp;</li><li>               RBC rates Western Digital at Outperform with a $115 price target (31% upside on yesterday&rsquo;s close).&nbsp;</li><li>               Analyst Amit Daryanani notes that the March quarter showed better gross margins than expected and that the margin forecast of 42% to 43% &ldquo;should provide investors conviction that even if there are NAND price declines the company should be able to comfortably generate &gt;40% gross margins in the foreseeable future.&rdquo;&nbsp;</li><li>               Cowen rates Western Digital at Outperform and cuts the price target by $7 to $110 (25% upside). &nbsp;&nbsp;</li><li>               Analyst Karl Ackerman says the company&rsquo;s NAND position remains healthy, but NAND won&rsquo;t be the upside lever it was last year.&nbsp;</li><li>               Ackerman says investors are focused on &ldquo;oscillating NAND ASPs&rdquo; since the major NAND players all anticipate growing supply toward the higher end of their outlooks.&nbsp;</li><li>               Analyst thinks robust hyperscale enterprise HDD and SDD business will drive FCF to a new record in 2018.&nbsp;</li><li>               Source: Bloomberg First Word&nbsp;</li><li>               Western Digital shares are&nbsp;<font color='red'>down 0.9%</font>&nbsp;to $87.18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325549-western-digital-minus-3_9-percent-despite-q2-beats-update\" target=\"_blank\">Western Digital -3.9% despite Q2 beats (update)</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325778\" data-linked=\"Analyst adjust Western Digital ratings, price targets after earnings\" data-tweet=\"$WDC - Analyst adjust Western Digital ratings, price targets after earnings https://seekingalpha.com/news/3325778-analyst-adjust-western-digital-ratings-price-targets-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3325778-analyst-adjust-western-digital-ratings-price-targets-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325776\" data-ts=\"1516986169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325776-consumer-top-gainers-losers-of-12-00-pm-1-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (1/26/2018)</a></h4><ul>     <li><b>Gainers:</b> ONP <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='green'>+6%</font></li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LCII' title='LCI Industries'>LCII</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325776\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (1/26/2018)\" data-tweet=\"$ITP $NBEV $SGOC - Consumer - Top Gainers / Losers as of 12:00 pm (1/26/2018) https://seekingalpha.com/news/3325776-consumer-top-gainers-losers-of-12-00-pm-1-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3325776-consumer-top-gainers-losers-of-12-00-pm-1-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325773\" data-ts=\"1516986003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PULM\" target=\"_blank\">PULM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325773-pulmatrix-adds-to-up-move-shares-ahead-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pulmatrix adds to up move, shares ahead 18%</a></h4><ul><li>Thinly traded nano cap Pulmatrix (<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='green'>+17.9%</font>) builds on yesterday's spike on a 10x surge in volume. Shares have rallied&nbsp;<font color='green'>38%</font>&nbsp;since then.</li><li>Consistent with other recent breakouts by tiny biotechs, no particular news accounts for the action.</li><li>Preclinical data on inhaled itraconazole Pulmazole will be <a href=\"https://seekingalpha.com/pr/17055352-pulmatrix-will-present-pulmazole-preclinical-data-8th-advances-aspergillosis-conference-held\" target=\"_blank\">presented </a>at the 8th Advances Against Aspergillosis Conference in Lisbon, Portugal next week.</li><li>A Phase 1/1b clinical trial assessing Pulmazole for the treatment of allergic bronchopulmonary aspergillosis in asthma patients should start soon.</li><li>At the end of Q3 2017, the company had $6.4M in cash and equivalents. Operations consumed $11.3M through the first three quarters.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325773\" data-linked=\"Pulmatrix adds to up move, shares ahead 18%\" data-tweet=\"$PULM - Pulmatrix adds to up move, shares ahead 18% https://seekingalpha.com/news/3325773-pulmatrix-adds-to-up-move-shares-ahead-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3325773-pulmatrix-adds-to-up-move-shares-ahead-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325771\" data-ts=\"1516985253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEE\" target=\"_blank\">NEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325771-nextera-exploring-potential-sale-of-canadian-portfolio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextEra exploring potential sale of Canadian portfolio</a></h4><ul>     <li>NextEra Energy (<a href='https://seekingalpha.com/symbol/NEE' title='NextEra Energy, Inc.'>NEE</a> <font color='green'>+1.6%</font>) yieldco NextEra Energy Partners (<a href='https://seekingalpha.com/symbol/NEP' title='NextEra Energy Partners, LP'>NEP</a> <font color='green'>+1.2%</font>) says it is considering the sale of Canadian wind and solar farms that total ~400 MW.</li>     <li>NEP execs said during today's earnings conference call that the company could recycle capital back into its U.S. assets if the sale is completed.</li>     <li>The move could allow the company to benefit from a &ldquo;longer federal income tax shield&rdquo; and retain more capital, NEP also said.</li><li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325771\" data-linked=\"NextEra exploring potential sale of Canadian portfolio\" data-tweet=\"$NEE $NEE $NEP - NextEra exploring potential sale of Canadian portfolio https://seekingalpha.com/news/3325771-nextera-exploring-potential-sale-of-canadian-portfolio?source=tweet\" data-url=\"https://seekingalpha.com/news/3325771-nextera-exploring-potential-sale-of-canadian-portfolio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325770\" data-ts=\"1516985027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGHT\" target=\"_blank\">EGHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325770-comms-firm-8x8-plus-12-analysts-praise-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comms firm 8x8 +12% as analysts praise Q3 beat</a></h4><ul>   <li>After earnings, 8x8 (NASDAQ:<a href='https://seekingalpha.com/symbol/EGHT' title='8X8 Inc'>EGHT</a>) is having its best day in nearly 20 years, now <font color='green'>up 12.4%</font> on a quarter where it <a href=\"https://seekingalpha.com/news/3325507-comms-firm-8x8-plus-7_1-percent-q3-beats\" target=\"_blank\">raised service revenues</a> by 20%.</li>    <li>The stock got price-target raises from B. Riley (to $16 from $14; B. Riley is Neutral on the stock) and from Needham (to $19 from $16).</li>    <li>Robert Baird, meanwhile, reiterated its Buy rating and $21 price target.</li>    <li>And pointing to a \"bounce back\" in new business, BofA Merrill Lynch has raised its target to $22, implying 37% upside from yesterday's close. The company continues to gain important enterprise reference customers, the firm notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325770\" data-linked=\"Comms firm 8x8 +12% as analysts praise Q3 beat\" data-tweet=\"$EGHT - Comms firm 8x8 +12% as analysts praise Q3 beat https://seekingalpha.com/news/3325770-comms-firm-8x8-plus-12-analysts-praise-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3325770-comms-firm-8x8-plus-12-analysts-praise-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325766\" data-ts=\"1516984480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLG\" target=\"_blank\">SLG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325766-sl-green-catches-upgrade-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SL Green catches upgrade at Stifel</a></h4><ul><li>Real estate valuations \"are simply too attractive to ignore,\" says analyst John Guinee, upgrading SL Green (NYSE:<a href='https://seekingalpha.com/symbol/SLG' title='SL Green Realty Corporation'>SLG</a>) to Buy from Hold. His $111 price target suggests about 15% upside.</li><li>One Vanderbilt, he says, could be the most significant single-building office development in the U.S. in the last 50 years, and rents will surprise investors to the upside.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='green'>+0.3%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3325766\" data-linked=\"SL Green catches upgrade at Stifel\" data-tweet=\"$SLG - SL Green catches upgrade at Stifel https://seekingalpha.com/news/3325766-sl-green-catches-upgrade-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3325766-sl-green-catches-upgrade-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325762\" data-ts=\"1516983096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325762-abbvie-continues-to-deliver-humira-shares-up-10-after-strong-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie continues to deliver with Humira; shares up 10% after strong Q4</a></h4><ul><li>AbbVie's (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+10%</font>) top seller HUMIRA (adalimumab) continues to be plump cash cow for the company. In a presentation at JPM18, CEO Rick Gonzalez said it will remain so for a few years to come since it has patent protection from biosimilars until 2022.</li><li>HUMIRA 2017 sales by quarter:</li><li>Q4: $4,892 (+14.0%).</li><li>Q3: $4,701 (+15.9%).</li><li>Q2: $4,716 (+13.7%).</li><li>Q1: $4,118 (+15.1%).</li><li>The relatively consistent growth rates are heavily influenced by the consistent price increases.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325677-abbvie-q4-revenues-14-percent-non-gaap-eps-23-percent-updates-guidance\" target=\"_blank\">AbbVie Q4 revenues up 14%; non-GAAP EPS up 23%; updates guidance</a> (Jan. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325762\" data-linked=\"AbbVie continues to deliver with Humira; shares up 10% after strong Q4\" data-tweet=\"$ABBV - AbbVie continues to deliver with Humira; shares up 10% after strong Q4 https://seekingalpha.com/news/3325762-abbvie-continues-to-deliver-humira-shares-up-10-after-strong-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3325762-abbvie-continues-to-deliver-humira-shares-up-10-after-strong-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325730\" data-ts=\"1516982481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325730-healthcare-gainers-losers-of-11-00-1-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am (1/26/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+90%</font>. <a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ABAX' title='ABAXIS, Inc.'>ABAX</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325730\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am (1/26/2018)\" data-tweet=\"$BSPM $CAPR $OASM - Healthcare Gainers / Losers as of 11:00 am (1/26/2018) https://seekingalpha.com/news/3325730-healthcare-gainers-losers-of-11-00-1-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3325730-healthcare-gainers-losers-of-11-00-1-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325756\" data-ts=\"1516982252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHL\" target=\"_blank\">AHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325756-aspen-insurance-down-12_5-after-q4-update-insurance-chief-fired\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aspen Insurance down 12.5% after Q4 update; insurance chief fired</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/17057143-aspen-announces-preliminary-estimate-fourth-quarter-2017-underwriting-loss-initial-assessment\" target=\"_blank\">company expects to book</a> an underwriting loss of about $245M in Q4, thanks to catastrophe losses as well as an increased frequency of mid-sized and attritional losses in the insurance operation.</li><li>Aspen (<a href='https://seekingalpha.com/symbol/AHL' title='Aspen Insurance Holdings Limited'>AHL</a> <font color='red'>-12.5%</font>) CEO Chris O'Kane: \"We are deeply disappointed with our financial performance ...&nbsp;We have taken a number of actions to improve our underwriting performance.\"</li><li>Among those actions: Aspen Insurance CEO Stephen Postlewhite <a href=\"https://seekingalpha.com/pr/17057574-aspen-announces-david-cohen-lead-insurance-segment\" target=\"_blank\">has been fired</a>. President and Chief Underwriting Officer David Cohen will take over his portfolio.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325756\" data-linked=\"Aspen Insurance down 12.5% after Q4 update; insurance chief fired\" data-tweet=\"$AHL - Aspen Insurance down 12.5% after Q4 update; insurance chief fired https://seekingalpha.com/news/3325756-aspen-insurance-down-12_5-after-q4-update-insurance-chief-fired?source=tweet\" data-url=\"https://seekingalpha.com/news/3325756-aspen-insurance-down-12_5-after-q4-update-insurance-chief-fired\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325754\" data-ts=\"1516982040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABAX\" target=\"_blank\">ABAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325754-abaxis-fq3-beat-propels-shares-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abaxis FQ3 beat propels shares, up 15%</a></h4><ul><li>Thinly traded Abaxis (<a href='https://seekingalpha.com/symbol/ABAX' title='ABAXIS, Inc.'>ABAX</a> <font color='green'>+14.9%</font>) is up in early trading on more than a 60% spike in volume, albeit on turnover of only 245K shares.</li><li>After the close yesterday, it <a href=\"https://seekingalpha.com/pr/17057006-abaxis-reports-financial-performance-third-quarter-fiscal-2018-declares-quarterly-cash\" target=\"_blank\">reported </a>fiscal Q3 non-GAAP EPS of $0.31 (-11.4%) on revenues of $59.7M (+12.9%), both above consensus. GAAP EPS was $0.18 (-40.0%).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325446-abaxis-beats-0_03-beats-revenue\" target=\"_blank\">abaxis beats by $0.03, beats on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325754\" data-linked=\"Abaxis FQ3 beat propels shares, up 15%\" data-tweet=\"$ABAX - Abaxis FQ3 beat propels shares, up 15% https://seekingalpha.com/news/3325754-abaxis-fq3-beat-propels-shares-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3325754-abaxis-fq3-beat-propels-shares-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325755\" data-ts=\"1516982035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325755-ge-slumps-to-16-analyst-sees-more-questions-answers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE slumps to $16 as analyst sees &#39;more questions than answers&#39;</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-1%</font>) shares slide again after J.P. Morgan's Stephen Tusa says there are still \"<a href=\"https://www.marketwatch.com/story/ges-stock-falls-toward-lowest-close-in-over-6-years-as-analyst-says-more-questions-remain-2018-01-26\" target=\"_blank\">more questions than answers</a>\" following the company's Q4 results and disclosure of an SEC investigation.</li>     <li>\"We don't know how a value investor or ratings agency analyst can have confidence in the ultimate value of assets here, most notably what's hung up on the industrial balance sheet, which will get a harder look by any potential buyer as the portfolio begins to come apart,\" writes Tusa, who rates GE at Underweight with a $16 price target.</li>     <li>Tusa views GE'a annual guidance as \"<a href=\"https://thefly.com/thestreet/realmoney/index.php/GEid2673271/GE-JPMorgan-calls-General-Electrics-annual-guidance-a-stretch\" target=\"_blank\">a stretch</a>,\" and continues to see a \"levered industrial company with weak levels of [free cash flow]... with a side dish of levered finco, with a management team in the tough position, working to prevent a 'hard landing' in which bond investors start to worry about liquidity.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3325755\" data-linked=\"GE slumps to $16 as analyst sees &#39;more questions than answers&#39;\" data-tweet=\"$GE - GE slumps to $16 as analyst sees &#39;more questions than answers&#39; https://seekingalpha.com/news/3325755-ge-slumps-to-16-analyst-sees-more-questions-answers?source=tweet\" data-url=\"https://seekingalpha.com/news/3325755-ge-slumps-to-16-analyst-sees-more-questions-answers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325752\" data-ts=\"1516981476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325752-twitter-gains-while-analysts-fade-coo-departure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter gains while analysts fade COO departure</a></h4><ul>   <li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) is making a move early today, <font color='green'>up 5.1%</font> to recoup a couple of days of declines.</li>    <li>On Yahoo, JP Mangalindan notes analysts <a href=\"https://finance.yahoo.com/news/twitter-coo-departure-spooked-investors-not-analysts-220005656.html\" target=\"_blank\">aren't quite as spooked</a> as investors are by the departure of COO Anthony Noto to run SoFi. A lot of what Noto put in place will continue, says Altimeter Group's Omar Akhtar.</li>    <li>Other analysts expressed similar sentiments. Noto's replaceable because Twitter has a \"deep bench,\" says Summit Redstone's Jonathan Kees, along with management alumni who might be available like former COO Adam Bain.</li>    <li>And JPMorgan's Douglas Anmuth says Noto's exit isn't \"thesis changing.\"</li>    <li>Shares have <font color='green'>gained 18.4%</font> over the past six months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325752\" data-linked=\"Twitter gains while analysts fade COO departure\" data-tweet=\"$TWTR - Twitter gains while analysts fade COO departure https://seekingalpha.com/news/3325752-twitter-gains-while-analysts-fade-coo-departure?source=tweet\" data-url=\"https://seekingalpha.com/news/3325752-twitter-gains-while-analysts-fade-coo-departure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325751\" data-ts=\"1516981459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325751-analysts-raise-kla-tencor-targets-after-earnings-discuss-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise KLA-Tencor targets after earnings, discuss guidance</a></h4><ul><li>        Needham raises its KLA-Tencor (NASDAQ:<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a>) price target by $5 to $135, a 1% upside on yesterday&rsquo;s closing price.</li><li>               Firm says outlook suggests a stable business, which means slower near-term growth compared to peers.&nbsp;</li><li>               Growth drivers include EUV, new products, and China and those could drive KLA-Tencor towards a better growth trajectory entering 2H18.&nbsp;</li><li>               Stifel reiterates Buy rating and $139 price target (4% upside).&nbsp;</li><li>               Firm says that KLA-Tencor provided a more modest March quarter outlook compared to Lam Research. While KLA has improved its memory exposure, Lam still has more concentration.</li><li>               Stifel expects momentum to pick up later in the year due to seasonal strength in the foundry/logic segment.&nbsp;</li><li>               B. Riley ups its price target from $129 to $142 (7% upside).&nbsp;</li><li>               Firm says bears will likely focus on the modest guidance but that 2018&rsquo;s favorable linearity refutes arguments of peak shipments.&nbsp;</li><li>               Source: Bloomberg First Word</li><li>               KLA-Tencor shares are&nbsp;<font color='green'>up 2.2%</font>&nbsp;to $115.55.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3325751\" data-linked=\"Analysts raise KLA-Tencor targets after earnings, discuss guidance\" data-tweet=\"$KLAC - Analysts raise KLA-Tencor targets after earnings, discuss guidance https://seekingalpha.com/news/3325751-analysts-raise-kla-tencor-targets-after-earnings-discuss-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325751-analysts-raise-kla-tencor-targets-after-earnings-discuss-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325750\" data-ts=\"1516981198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAPR\" target=\"_blank\">CAPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325750-capricor-breaks-out-of-consolidation-up-30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capricor breaks out of consolidation, up 30%</a></h4><ul><li>Capricor Therapeutics (<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='green'>+29.6%</font>) has cleared near-term consolidation on triple normal volume.</li><li>Ten days ago, it announced that it had expanded its licensing deal with Cedars-Sinai Medical Center, securing exclusive global rights to develop cardiosphere-derived cells (CDCs) and other candidates.</li><li>A Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03406780?titles=hope-2&amp;spons=capricor&amp;rank=1\" target=\"_blank\">HOPE-2</a>, assessing Duchenne muscular dystrophy candidate CAP-1002 is poised to start enrollment.</li><li>At the end of September 2017, the company had ~$13.9M in quick assets. Operations consumed $11.6M through the first three quarters.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3322834-capricor-licenses-additional-patent-applications-cedars-sinai-medical-center-cellular-exosome\" target=\"_blank\">Capricor licenses additional patent applications from Cedars-Sinai Medical Center for cellular and exosome-based technologies</a> (Jan. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325750\" data-linked=\"Capricor breaks out of consolidation, up 30%\" data-tweet=\"$CAPR - Capricor breaks out of consolidation, up 30% https://seekingalpha.com/news/3325750-capricor-breaks-out-of-consolidation-up-30?source=tweet\" data-url=\"https://seekingalpha.com/news/3325750-capricor-breaks-out-of-consolidation-up-30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325746\" data-ts=\"1516980416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325746-mcdermott-cb-and-i-merger-clears-u-s-antitrust-hurdle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott-CB&amp;I merger clears U.S. antitrust hurdle</a></h4><ul><li>The planned $6B merger of McDermott International (NYSE:<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a>) and Chicago Bridge &amp;&nbsp;Iron (NYSE:<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a>) <a href=\"http://splash247.com/planned-merger-mcdermott-cbi-clears-us-antitrust-hurdle/\" target=\"_blank\">clears an antitrust hurdle</a>, as the U.S. Federal Trade Commission granted early termination of a required waiting period.</li><li>The Hart-Scott-Rodino Act of 1976 establishes waiting periods that typically must elapse in order for a merger to be assessed for its impact on market competition.</li><li>The proposed tie-up now only needs approval for the shareholders of the two companies, completion of financing and some other conditions, and regulatory clearance in Russia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325746\" data-linked=\"McDermott-CB&amp;I merger clears U.S. antitrust hurdle\" data-tweet=\"$MDR $MDR $CBI - McDermott-CB&amp;I merger clears U.S. antitrust hurdle https://seekingalpha.com/news/3325746-mcdermott-cb-and-i-merger-clears-u-s-antitrust-hurdle?source=tweet\" data-url=\"https://seekingalpha.com/news/3325746-mcdermott-cb-and-i-merger-clears-u-s-antitrust-hurdle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325744\" data-ts=\"1516979212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AJG\" target=\"_blank\">AJG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325744-arthur-j-gallagher-co-acquires-market-financial-group-austin-consulting-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arthur J. Gallagher &amp; Co. acquires Market Financial Group &amp; Austin Consulting Group</a></h4><ul>     <li>Arthur J. Gallagher &amp; Co. (<a href='https://seekingalpha.com/symbol/AJG' title='Arthur J.Gallagher & Co.'>AJG</a> <font color='green'>+5.7%</font>) announced the acquisition of Crystal Lake, Illinois-based Market Financial Group &amp; its affiliate, Austin Consulting Group. Terms of the transaction were not disclosed.</li>     <li>Market Financial Group is a risk management and human resources consultant and broker providing property/casualty and human resources solutions in Illinois. Austin Consulting Group is an insurance consultant, finance &amp; insurance advocate.</li>     <li>\"Market Financial Group and Austin Consulting Group are complementary, well-run businesses with a marketing approach that is closely aligned with Gallagher's,\" said J. Patrick Gallagher, Jr., Chairman, President and CEO. \"I am excited to welcome Rich, Rob, Ken and their associates to our growing Gallagher family of professionals.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325744\" data-linked=\"Arthur J. Gallagher &amp; Co. acquires Market Financial Group &amp; Austin Consulting Group\" data-tweet=\"$AJG - Arthur J. Gallagher &amp; Co. acquires Market Financial Group &amp; Austin Consulting Group https://seekingalpha.com/news/3325744-arthur-j-gallagher-co-acquires-market-financial-group-austin-consulting-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3325744-arthur-j-gallagher-co-acquires-market-financial-group-austin-consulting-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325739\" data-ts=\"1516978963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSPM\" target=\"_blank\">BSPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325739-biostar-pharma-jumps-out-of-blocks-up-108\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biostar pharma jumps out of the blocks, up 108%</a></h4><ul><li>Thinly traded nano cap Biostar Pharmaceuticals (<a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+107.8%</font>) is the top gainer in the market this morning. Shares are up on a whopping 58x surge in volume only 30 minutes into the session on no particular news.</li><li>The Xiangyang, China-based firm sells its products in-country. Top seller is Xin Ao Xing Oleanolic Acid Capsules for the treatment of hepatitis B.</li><li>At the end of September 2017, the company had only <a href=\"https://www.sec.gov/Archives/edgar/data/1418133/000118518517002435/biostar10q093017.htm#Item1.Condensed\" target=\"_blank\">$365K in cash</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299983-biostar-42-percent-news-scarce\" target=\"_blank\">Biostar up 42% but news scarce</a> (Oct. 9, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325739\" data-linked=\"Biostar pharma jumps out of the blocks, up 108%\" data-tweet=\"$BSPM - Biostar pharma jumps out of the blocks, up 108% https://seekingalpha.com/news/3325739-biostar-pharma-jumps-out-of-blocks-up-108?source=tweet\" data-url=\"https://seekingalpha.com/news/3325739-biostar-pharma-jumps-out-of-blocks-up-108\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325740\" data-ts=\"1516978952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325740-morgan-stanley-bull-case-puts-amazon-over-1t-market-cap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley bull case puts Amazon over $1T market cap</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.cnbc.com/2018/01/26/morgan-stanleys-bull-case-for-amazon-sees-online-giant-worth-1-trillion-in-12-months.html\" target=\"_blank\">increases</a> its Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) price target from $1,260 to $1,400, a 1.6% upside on yesterday&rsquo;s close.</li><li>               Firm raises its bull case price target by $100 to $2,100, which would give Amazon an over $1T market cap.&nbsp;</li><li>               Analyst Brian Nowak says he underestimated the ad aspect of Amazon&rsquo;s business and the firm remains &ldquo;bullish Amazon&rsquo;s ad opportunity as the company continues to drive its high margin revenue stream businesses that enable it to invest harder than ever and deliver upward revisions.&rdquo;&nbsp;</li><li>               Nowak estimates that Amazon&rsquo;s sponsored ad business will grow 54% per year from 2016 to 2019.&nbsp;</li><li>           Morgan Stanley maintains an Overweight rating on Amazon.&nbsp; </li><li>                  Amazon shares are&nbsp;<font color='green'>up 1%</font>&nbsp;to $1,392.03.&nbsp;<br />    &nbsp;           </li></ul><div class=\"tiny-share-widget\" data-id=\"3325740\" data-linked=\"Morgan Stanley bull case puts Amazon over $1T market cap\" data-tweet=\"$AMZN - Morgan Stanley bull case puts Amazon over $1T market cap https://seekingalpha.com/news/3325740-morgan-stanley-bull-case-puts-amazon-over-1t-market-cap?source=tweet\" data-url=\"https://seekingalpha.com/news/3325740-morgan-stanley-bull-case-puts-amazon-over-1t-market-cap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>184&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325729\" data-ts=\"1516977548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WGO\" target=\"_blank\">WGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325729-northcoast-cautious-on-rv-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northcoast cautious on RV sector</a></h4><ul> <li>Northcoast Research lowers Winnebago (<a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color='red'>-5.9%</font>) and Thor Industries (<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='red'>-4.9%</font>) to a Neutral rating from Buy due to concerns that dealer inventory is at an \"unsustainable level\" for 2018.</li> <li>The firm is more comfortable with Camping World (<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='green'>+0.7%</font>) as a RV play and&nbsp; initiates the stock with a Buy rating and $56 price target.</li> <li>Sources: CNBC and Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325729\" data-linked=\"Northcoast cautious on RV sector\" data-tweet=\"$WGO $WGO $THO - Northcoast cautious on RV sector https://seekingalpha.com/news/3325729-northcoast-cautious-on-rv-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3325729-northcoast-cautious-on-rv-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325728\" data-ts=\"1516977207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325728-rosenblatt-btig-disagree-on-apples-q1-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosenblatt, BTIG disagree on Apple&#39;s Q1 potential</a></h4><ul><li>        Rosenblatt Securities thinks Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) will beat analyst estimates in Q1 due to higher-than-expected iPhone X production in the period.</li><li>               Analyst Jun Zhang calls risks in Q1 &ldquo;overblown&rdquo; even though Apple&rsquo;s forecast could come in below analyst estimates as iPhone sales decelerate.&nbsp;</li><li>               Zhang expects Apple to recognize a portion of iPhone X units produced in December and iPhone SE2 shipments that could begin in early March.&nbsp;</li><li>                  Firm rates Apple at Buy with a $180 price target, a 5% upside on yesterday&rsquo;s close.   </li><li>               More action: BTIG analyst Walter Piecyck thinks Apple will guide March quarter revenues as low as $60B (consensus: $68B).</li><li>               Piecyck writes that smartphone upgrade rates remain at record lows and don&rsquo;t appear ready for a Q1 rebound since customers are simply holding onto their phones longer.&nbsp;</li><li>                  BTIG rates Apple at Buy with a $198 price target, a 15% upside on yesterday&rsquo;s close.    </li><li>               Source: Bloomberg First Word &nbsp;&nbsp;</li><li>               Apple will report earnings on February 1.&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 0.4%</font>&nbsp;to $171.79.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3325728\" data-linked=\"Rosenblatt, BTIG disagree on Apple&#39;s Q1 potential\" data-tweet=\"$AAPL - Rosenblatt, BTIG disagree on Apple&#39;s Q1 potential https://seekingalpha.com/news/3325728-rosenblatt-btig-disagree-on-apples-q1-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3325728-rosenblatt-btig-disagree-on-apples-q1-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325724\" data-ts=\"1516976795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325724-senseonics-prices-convertible-debt-offering-shares-down-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senseonics prices convertible debt offering; shares down 3% premarket</a></h4><ul><li>Thinly traded micro cap Senseonics (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a>) slips&nbsp;<font color='red'>3%&nbsp;</font>premarket on modest volume in response to its <a href=\"https://seekingalpha.com/pr/17057476-senseonics-announces-pricing-50-million-convertible-notes-offering\" target=\"_blank\">$50M offering </a>of 5.25% convertible senior subordinated notes due 2023. The initial conversion rate will be 294.1176 common shares per $1,000 principal amount (~$3.40/share).</li><li>The underwriter's over-allotment is an additional $7.5M of the notes. Closing date is January 30.</li><li>Net proceeds should be ~$48M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325724\" data-linked=\"Senseonics prices convertible debt offering; shares down 3% premarket\" data-tweet=\"$SENS - Senseonics prices convertible debt offering; shares down 3% premarket https://seekingalpha.com/news/3325724-senseonics-prices-convertible-debt-offering-shares-down-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3325724-senseonics-prices-convertible-debt-offering-shares-down-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325721\" data-ts=\"1516976485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325721-pareteumplus-8-amid-new-8_7m-emea-network-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +8% amid new \u20ac8.7M EMEA network deal</a></h4><ul>   <li>Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color='green'>up a sharp 8%</font> premarket after announcing its Pareteum Europe unit has <a href=\"https://seekingalpha.com/pr/17057306-pareteum-europe-awarded-guaranteed-8_7-million-euro-contract-managed-service-platform-5-years\" target=\"_blank\">signed an &euro;8.7M deal</a> with a new customer in EMEA.</li>    <li>The five-year extensible deal is to act as a mobile virtual network enabler for the customer.</li>    <li>A large base of existing subscribers will be put on the platform at first, with all new mobile subscribers placed going forward. That means significant up-front fees along with guaranteed minimum subscriber volumes later.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325721\" data-linked=\"Pareteum +8% amid new \u20ac8.7M EMEA network deal\" data-tweet=\"$TEUM - Pareteum +8% amid new \u20ac8.7M EMEA network deal https://seekingalpha.com/news/3325721-pareteumplus-8-amid-new-8_7m-emea-network-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3325721-pareteumplus-8-amid-new-8_7m-emea-network-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325719\" data-ts=\"1516976380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMNY\" target=\"_blank\">HMNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325719-investors-eye-moviepass-amc-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors eye MoviePass-AMC development</a></h4><ul> <li>Premarket volume on Helios and Matheson Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>) is over 103K shares as investors continue to trade vigorously on MoviePass news.</li> <li>MoviePass walked out the Sundance Film Festival as an indie movie buyer, but Deadline is <a href=\"http://deadline.com/2018/01/moviepass-lack-of-amc-theatres-coverage-1202269412/\" target=\"_blank\">reporting</a> that some AMC theaters in large cities aren't accepting MoviePass anymore in what could turn into a major development if confirmed.</li><li>AMC Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a>) hasn't been a wholehearted supporter of MoviePass from the start.</li> <li>HMNY is<font color='red'> down 3.7%</font> in the premarket session to $8.60.</li><li><strong>Update</strong>: MoviePass has confirmed that it's no longer allowing its service to be used at AMC theaters and is going to battle against the chain over revenue sharing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325719\" data-linked=\"Investors eye MoviePass-AMC development\" data-tweet=\"$HMNY $HMNY $AMC - Investors eye MoviePass-AMC development https://seekingalpha.com/news/3325719-investors-eye-moviepass-amc-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3325719-investors-eye-moviepass-amc-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325714\" data-ts=\"1516976114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/Z\" target=\"_blank\">Z</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325714-zillowplus-2_6-keybanc-moves-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow +2.6% as KeyBanc moves to Overweight</a></h4><ul>   <li>Zillow Group (NASDAQ:<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a>) is <font color='green'>up 2.6%</font> premarket after a raise to Overweight at KeyBanc, from Sector Weight.</li>    <li>That gets it off a fence where analysts are nearly evenly split between Buy and Hold calls. The firm set its price target at $54, implying 22.2% upside.</li>    <li>Shares have <font color='green'>appreciated 20.2%</font> over the past 12 months.</li>    <li>The company is set to report earnings Feb. 6 after the closing bell.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325714\" data-linked=\"Zillow +2.6% as KeyBanc moves to Overweight\" data-tweet=\"$Z - Zillow +2.6% as KeyBanc moves to Overweight https://seekingalpha.com/news/3325714-zillowplus-2_6-keybanc-moves-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3325714-zillowplus-2_6-keybanc-moves-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325712\" data-ts=\"1516975879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325712-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a> <font color='green'>+39%</font>.</li><li><a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='green'>+10%</font> on <a href=\"https://seekingalpha.com/news/3325577-gastar-exploration-sell-oklahoma-acreage-107m\" target=\"_blank\">selling Oklahoma</a> acreage.</li><li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/symbol/EGHT' title='8X8 Inc'>EGHT</a> <font color='green'>+9%</font> on <a href=\"https://seekingalpha.com/news/3325507-comms-firm-8x8-plus-7_1-percent-q3-beats\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+7%</font> on <a href=\"https://seekingalpha.com/news/3325519-intel-plus-4_5-percent-q4-beats-data-center-growth-upside-guidance\" target=\"_blank\">Q4 earnings</a>.</li><li>ITUS <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+6%</font> on regaining <a href=\"https://seekingalpha.com/news/3325397-size-plus-11_8-regaining-nasdaq-compliance\" target=\"_blank\">Nasdaq compliance</a>.</li><li><a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a> <font color='green'>+5%</font> on <a href=\"https://seekingalpha.com/news/3325592-wsj-dell-examines-alternatives-including-ipo-vmware-buyout\" target=\"_blank\">potential buyout</a> by Dell.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3325712\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$LMFA $GST $TEUM - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3325712-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3325712-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325710\" data-ts=\"1516975799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325710-new-age-beveragesplus-8-on-coconut-water-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages +8% on coconut water news</a></h4><ul> <li>Shares of New Age Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color='green'>jump 8%</font> in premarket trading after the company starts <a href=\"https://seekingalpha.com/news/3325623-new-age-beverages-begins-shipments-nationally-new-organic-coco-libre-sparkling-coconut-water\" target=\"_blank\">shipping</a> its Coco-Libre Sparking coconut water product to major retail customers.</li> <li>NBEV has traded as high as $4.00 in the premarket session to mark the first time it has crossed the threshold since last September.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325623-new-age-beverages-begins-shipments-nationally-new-organic-coco-libre-sparkling-coconut-water\" target=\"_blank\">New Age Beverages begins shipments nationally of its new organic Coco-Libre Sparkling coconut water</a> (Jan. 26)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3325710\" data-linked=\"New Age Beverages +8% on coconut water news\" data-tweet=\"$NBEV - New Age Beverages +8% on coconut water news https://seekingalpha.com/news/3325710-new-age-beveragesplus-8-on-coconut-water-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3325710-new-age-beveragesplus-8-on-coconut-water-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325708\" data-ts=\"1516975596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LTBR\" target=\"_blank\">LTBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325708-premarket-losers-of-9-05-1-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (1/26/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corporation'>LTBR</a> <font color='red'>-13%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3325708\" data-linked=\"Premarket Losers as of 9:05 am (1/26/2018)\" data-tweet=\"$LTBR - Premarket Losers as of 9:05 am (1/26/2018) https://seekingalpha.com/news/3325708-premarket-losers-of-9-05-1-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3325708-premarket-losers-of-9-05-1-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325706\" data-ts=\"1516975464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325706-keybanc-raises-alibaba-price-target-to-16-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc raises its Alibaba price target to 16% upside</a></h4><ul><li>        KeyBanc raises its Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) price target by $20 to $230, which is a nearly 16% upside on yesterday&rsquo;s closing price.&nbsp;</li><li>           Firm maintains an Overweight rating. </li><li>           Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=BABA:NYQ\" target=\"_blank\">recommendations</a>: 22 Buy, 26 Outperform, and 1 Hold. &nbsp; </li><li>           Alibaba shares are&nbsp;<font color='green'>up 1.3%</font>&nbsp;premarket to $200.92.&nbsp;&nbsp; </li></ul> &nbsp;<br /><div class=\"tiny-share-widget\" data-id=\"3325706\" data-linked=\"KeyBanc raises its Alibaba price target to 16% upside\" data-tweet=\"$BABA - KeyBanc raises its Alibaba price target to 16% upside https://seekingalpha.com/news/3325706-keybanc-raises-alibaba-price-target-to-16-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3325706-keybanc-raises-alibaba-price-target-to-16-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325705\" data-ts=\"1516975461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325705-mnuchin-walks-back-weak-dollar-comment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mnuchin walks back weak dollar comment</a></h4><ul><li>Appearing on CNBC, the Treasury Secretary claims he wasn't trying to move the greenback on Wednesday when he said \"a weak dollar is good for us.\" Uh-huh. The end of Davos and the weekend can't come fast enough.</li><li>The dollar today is&nbsp;<font color='red'>off about 0.4%</font>, depending upon which index you follow.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>, <a href='https://seekingalpha.com/symbol/UDN' title='PowerShares DB USD Bear ETF'>UDN</a>, <a href='https://seekingalpha.com/symbol/USDU' title='WisdomTree Bloomberg U.S. Dollar Bullish ETF'>USDU</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3324888-dollars-decline-deepens-mnuchin-comments\" target=\"_blank\">Dollar's decline deepens after Mnuchin comments</a> (Jan. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325705\" data-linked=\"Mnuchin walks back weak dollar comment\" data-tweet=\"$UUP $UDN $USDU - Mnuchin walks back weak dollar comment https://seekingalpha.com/news/3325705-mnuchin-walks-back-weak-dollar-comment?source=tweet\" data-url=\"https://seekingalpha.com/news/3325705-mnuchin-walks-back-weak-dollar-comment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325693\" data-ts=\"1516974336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325693-invivo-therapeutics-inks-15m-stock-purchase-deal-shares-ahead-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo Therapeutics inks $15M stock purchase deal; shares ahead 8% premarket</a></h4><ul><li>Thinly traded nano cap InVivo Therapeutics Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a>) is up&nbsp;<font color='green'>8%&nbsp;</font>premarket on modest volume in response to its <a href=\"https://seekingalpha.com/pr/17057452-invivo-therapeutics-announces-purchase-agreement-15-million-lincoln-park-capital\" target=\"_blank\">announcement </a>that it has entered into a common stock purchase with Lincoln Park Capital Fund, LLC to sell it up to $15M of stock over a two-year period. No warrants are involved.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325693\" data-linked=\"InVivo Therapeutics inks $15M stock purchase deal; shares ahead 8% premarket\" data-tweet=\"$NVIV - InVivo Therapeutics inks $15M stock purchase deal; shares ahead 8% premarket https://seekingalpha.com/news/3325693-invivo-therapeutics-inks-15m-stock-purchase-deal-shares-ahead-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3325693-invivo-therapeutics-inks-15m-stock-purchase-deal-shares-ahead-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325689\" data-ts=\"1516973948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYNE\" target=\"_blank\">ZYNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325689-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Zynerba Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a>), BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>), Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) and Aerie Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a>) all initiated with Buy ratings at Seaport Global Securities.</li><li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) initiated with Buy rating and $18 (223% upside) price target at Nomura. Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume.</li><li>Sucampo Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SCMP' title='Sucampo Pharmaceuticals, Inc.'>SCMP</a>) downgraded to Neutral with an $18 (flat) price target at Nomura.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325689\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ZYNE $ZYNE $BDSI - Premarket analyst action - healthcare https://seekingalpha.com/news/3325689-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3325689-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325680\" data-ts=\"1516973048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325680-holiday-offers-dud-for-starbucks-while-shanghai-shines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Holiday offers a dud for Starbucks while Shanghai shines</a></h4><ul> <li>Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) execs admitted on yesterday's conference call that holiday offers and merchandise didn't resonate with consumers as planned despite what was a solid period in the U.S. retail sector. \"Our core beverage comp, excluding holiday limited time offers was 1 percent. And together our holiday LTO and lobby items had a negative impact of over 1 point of comp,\" noted CEO Kevin Johnson.</li> <li>Management also maintained that the company was not losing business to cannibalization or rising competition from other coffee sellers.</li> <li>One area that went exceedingly well for Starbucks was China, where same-store sales were up 6%. The coffee chain's new Reserve Roastery in Shanghai in particular was a smashing success. Starbucks Chairman Howard Schultz noted that while U.S. Starbucks stores average about $32K a week in business, the Reserve Roastery in Shanghai is averaging twice that each day after eight weeks of being open.</li><li>There's is plenty of buzzing on Starbucks from Wall Street this morning, including Goldman Sachs removing the stock from its Conviction List. Piper Jaffray (Overweight, $70 PT) and Bank of America Merril Lynch (Buy, $66 PT) both issued a positive assessment on the long-term story with Starbucks,</li> <li>Sources: <a href=\"https://www.cnbc.com/2018/01/25/eight-weeks-in-starbucks-shanghai-roastery-is-raking-in-insane-sales.html\" target=\"_blank\">CNBC</a>, <a href=\"https://seekingalpha.com/article/4140366-starbucks-sbux-ceo-kevin-johnson-q1-2018-results-earnings-call-transcript\" target=\"_blank\">Starbucks earnings call conference</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3325483-starbucks-lower-comparable-sales-disappoint\" target=\"_blank\">Starbucks lower after comparable sales disappoint</a> (Jan. 25)</li><li>SBUX&nbsp;<font color='red'>-4.77%</font>&nbsp;in premarket trading to $57.66.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325680\" data-linked=\"Holiday offers a dud for Starbucks while Shanghai shines\" data-tweet=\"$SBUX - Holiday offers a dud for Starbucks while Shanghai shines https://seekingalpha.com/news/3325680-holiday-offers-dud-for-starbucks-while-shanghai-shines?source=tweet\" data-url=\"https://seekingalpha.com/news/3325680-holiday-offers-dud-for-starbucks-while-shanghai-shines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325679\" data-ts=\"1516972968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNTX\" target=\"_blank\">GNTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325679-gentex-higher-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gentex higher on earnings beat</a></h4><ul><li>Gentex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a>)&nbsp;reports Automotive net sales rose 2% to $450.4M in <a href=\"https://seekingalpha.com/pr/17057465-gentex-reports-fourth-quarter-year-end-2017-financial-results\" target=\"_blank\">Q4</a>, due to 13% rise in auto-dimming mirror unit shipments sequentially.</li><li>Total auto-dimming mirror units +1,127 Y/Y to 10,023.</li><li>Gross margin rate squeezed 110 bps to 39.2%.</li><li>Operating margin rate fell 130 bps to 29.2%.</li><li><b>FY2018 Guidance</b>: Net sales: $1.89B to $1.97B; Gross margin rate: 38% to 39%; Operating expense: $180M to $190M; Tax rate: 18% to 21%; Capex: $115M to $130M; D&amp;A: $105M to $115M.</li><li>GNTX <font color='green'>+6.64%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325679\" data-linked=\"Gentex higher on earnings beat\" data-tweet=\"$GNTX - Gentex higher on earnings beat https://seekingalpha.com/news/3325679-gentex-higher-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3325679-gentex-higher-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325677\" data-ts=\"1516972966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325677-abbvie-q4-revenues-up-14-non-gaap-eps-up-23-updates-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie Q4 revenues up 14%; non-GAAP EPS up 23%; updates guidance</a></h4><ul><li>AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+2.6%</font>) <a href=\"https://seekingalpha.com/pr/17057415-abbvie-reports-full-year-fourth-quarter-2017-financial-results\" target=\"_blank\">Q4 results</a>: Revenues: $7,739M (+13.9%); Operating Income: $1,794M (-23.9%); Net Income: $52M (-96.3%); EPS: $0.03 (-96.5%); Non-GAAP EPS: $1.48 (+23.3%).</li><li>Key Product Sales: Humira: $4,892M (+14.0%); Imbruvica: $708M (+38.7%); HCV: $510M (+63.4%); Lupron: $224M (+2.2%); Creon: $235M (+10.6%); Synagis: $282M; Synthroid: $205M; AndroGel: $140M (-19.6%); Kaletra: $113M (-14.3%); Sevoflurane: $99M (-1.5%); Duodopa: $100M (+27.6%).</li><li><strong>2018 Guidance</strong>: Revenue: $32B; GAAP EPS: $6.45 - 6.55; Non-GAAP EPS: $7.33 - 7.43 from $6.37 - 6.57.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325677\" data-linked=\"AbbVie Q4 revenues up 14%; non-GAAP EPS up 23%; updates guidance\" data-tweet=\"$ABBV - AbbVie Q4 revenues up 14%; non-GAAP EPS up 23%; updates guidance https://seekingalpha.com/news/3325677-abbvie-q4-revenues-up-14-non-gaap-eps-up-23-updates-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325677-abbvie-q4-revenues-up-14-non-gaap-eps-up-23-updates-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325678\" data-ts=\"1516972913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325678-solid-biosciences-debuts-today-after-disclosure-misstep\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid Biosciences debuts today after disclosure misstep</a></h4><ul><li>Trading in IPO&nbsp;Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a>) kicks off today after an embarrassing gaff related its <a href=\"https://www.sec.gov/Archives/edgar/data/1707502/000119312518019022/d404258dfwp.htm\" target=\"_blank\">failure to disclose </a>an FDA-stipulated partial clinical hold on its Phase 1/2 study assessing Duchenne muscular dystrophy &#40;DMD&#41; candidate SGT-001.</li><li>The company received the communication from the FDA in November 2017 citing the need for the company to demonstrate that it has the appropriate manufacturing processes in place to support the higher-dose group. Low-dose SGT-001 is not affected.</li><li>The matter appears routine, but the company's stumble has forced it to lower its offering price to $16 a share from the expected range of $18 - 19 that it announced only two days ago.</li><li>DMD leader Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) is, no doubt, following the action with interest.</li><li><strong>Update</strong>: Indicating an opening of $24.</li><li><strong>Update</strong>: Shares opened at $25.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325678\" data-linked=\"Solid Biosciences debuts today after disclosure misstep\" data-tweet=\"$SLDB $SLDB $SRPT - Solid Biosciences debuts today after disclosure misstep https://seekingalpha.com/news/3325678-solid-biosciences-debuts-today-after-disclosure-misstep?source=tweet\" data-url=\"https://seekingalpha.com/news/3325678-solid-biosciences-debuts-today-after-disclosure-misstep\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325675\" data-ts=\"1516972255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325675-amd-nvidia-on-move-after-intels-earnings-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD, Nvidia on the move after Intel&#39;s earnings report</a></h4><ul><li>        Intel peers are moving premarket following yesterday&rsquo;s earnings report.&nbsp;</li><li>        AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) shares are&nbsp;<font color='green'>up 2%</font>&nbsp;to $12.66. AMD reports earnings on January 30.</li><li>           Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) shares are&nbsp;<font color='green'>up 0.7%</font>&nbsp;to $238.09. Nvidia reports earnings on February 7. &nbsp;&nbsp; </li><li>    Previously: <a href=\"https://seekingalpha.com/news/3325519-intel-plus-4_5-percent-q4-beats-data-center-growth-upside-guidance\" target=\"_blank\">Intel +4.5% on Q4 beats, data center growth, upside guidance</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325675\" data-linked=\"AMD, Nvidia on the move after Intel&#39;s earnings report\" data-tweet=\"$AMD $AMD $NVDA - AMD, Nvidia on the move after Intel&#39;s earnings report https://seekingalpha.com/news/3325675-amd-nvidia-on-move-after-intels-earnings-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3325675-amd-nvidia-on-move-after-intels-earnings-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325672\" data-ts=\"1516972178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNTX\" target=\"_blank\">GNTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325672-gentex-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gentex beats by $0.01, beats on revenue</a></h4><ul><li>Gentex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a>): Q4 EPS of $0.33 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $459.6M (+9.5% Y/Y) <font color='green'>beats by $9.73M</font>.</li><li>Shares <font color='green'>+6.6%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17057465-gentex-reports-fourth-quarter-year-end-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3325672\" data-linked=\"Gentex beats by $0.01, beats on revenue\" data-tweet=\"$GNTX - Gentex beats by $0.01, beats on revenue https://seekingalpha.com/news/3325672-gentex-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3325672-gentex-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325662\" data-ts=\"1516971525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325662-jefferies-bullish-on-gilead-sees-17-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies bullish on Gilead, sees 17% upside</a></h4><ul><li>Jefferies' Michael Yee upgrades Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) to Buy and raises his price target to $95 (17% upside) from $87 citing positive prospects for CAR-T therapy Yescarta (axicabtagene ciloleucel) and its HIV franchise.</li><li>Other positives include arthritis candidate filgotinib (with Galapagos NV) and NASH candidate selonsertib.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3325662\" data-linked=\"Jefferies bullish on Gilead, sees 17% upside\" data-tweet=\"$GILD - Jefferies bullish on Gilead, sees 17% upside https://seekingalpha.com/news/3325662-jefferies-bullish-on-gilead-sees-17-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3325662-jefferies-bullish-on-gilead-sees-17-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>176&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325660\" data-ts=\"1516971330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEA\" target=\"_blank\">LEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325660-on-lears-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Lear&#39;s Q3</a></h4><ul><li>Lear (NYSE:<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a>) reports sales rose 11% in <a href=\"https://seekingalpha.com/pr/17057386-lear-reports-record-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4</a>,&nbsp;after excluding the currency impact.</li><li>Segment sales: Seating: $4.11B (+14.2%);&nbsp;E-Systems: $1.25B (+20.2%)</li><li>Net sales in North America +8.7% to $1.95B; Europe and Africa +29% to $2.16B; Asia +5.5% to $1.06B;&nbsp;South America +13% to $189.1M.</li><li>Gross margin rate down 30 bps to 10.7%.</li><li>Adjusted segment earnings: Seating: $333.9M (-10 bps to 8.1%);&nbsp;E-Systems: $179.6M (+50 bps to 14.3%).</li><li>Core operating margin rate -10 bps to 8.2%.</li><li><b>FY2018 Guidance</b>: Sales: ~$21.4B to $21.6B; Core operating earnings: ~$1.75B to $1.775B; Tax rate: ~22%; Adjusted net income: ~$1.23B to $1.25B; Capex: $630M;&nbsp;Free cash flow: more than $1.2B; D&amp;A: $480M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325660\" data-linked=\"More on Lear&#39;s Q3\" data-tweet=\"$LEA - More on Lear&#39;s Q3 https://seekingalpha.com/news/3325660-on-lears-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3325660-on-lears-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325659\" data-ts=\"1516971318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLEX\" target=\"_blank\">FLEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325659-flexplus-1-on-q3-beats-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flex +1% on Q3 beats, in-line guidance</a></h4><ul><li>        Flex (NASDAQ:<a href='https://seekingalpha.com/symbol/FLEX' title='Flex Ltd..'>FLEX</a>) shares are&nbsp;<font color='green'>up 1%</font>&nbsp;premarket after yesterday&rsquo;s Q3 report beat earnings and EPS estimates. In-line Q4 guidance has revenue from $6.1B to $6.5B (consensus: $6.16B) and EPS from $0.28 to $0.32 (consensus: $0.29).</li><li>               Key metrics: Cash from operations, $150M; cash on hand, $1.3B; total debt, $2.9B.&nbsp;</li><li>               Restructuring: Company plans to initiate restructuring activities in Q4. Detailed plan not yet finalized, but Flex expects to incur a minimum charge of $50M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17057038-flex-reports-third-quarter-fiscal-2018-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325460-flex-beats-0_01-beats-revenue\" target=\"_blank\">Flex beats by $0.01, beats on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325659\" data-linked=\"Flex +1% on Q3 beats, in-line guidance\" data-tweet=\"$FLEX - Flex +1% on Q3 beats, in-line guidance https://seekingalpha.com/news/3325659-flexplus-1-on-q3-beats-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325659-flexplus-1-on-q3-beats-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325657\" data-ts=\"1516971144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325657-abbvie-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie beats by $0.04, beats on revenue</a></h4><ul><li>AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>): Q4 EPS of $1.48 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $7.74B (+13.8% Y/Y) <font color='green'>beats by $210M</font>.</li><li>Shares <font color='green'>+1.57%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17057415-abbvie-reports-full-year-fourth-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3325657\" data-linked=\"AbbVie beats by $0.04, beats on revenue\" data-tweet=\"$ABBV - AbbVie beats by $0.04, beats on revenue https://seekingalpha.com/news/3325657-abbvie-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3325657-abbvie-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325655\" data-ts=\"1516970630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325655-united-rentals-made-top-pick-baml\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Rentals made a top pick at BAML</a></h4><ul><li>BAML buys the post-earnings dip in United Rentals (NYSE:<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a>), adding the stock to its US1 List, and boosting the price target to $230 from $195 (<font color='green'>26% upside</font>).</li><li>Analyst Ross Gilardi sees a recovery in U.S. capital spending, leading to improving demand, greater pricing power, and stronger free cash flow.</li><li>Assuming 6% revenue growth, 60% EBITDA pass-through, and $6B of free cash flow (with half going to buyback, half to acquisitions), this could be a $300 stock in two years, says Gilardi.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='green'>up 0.35%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3325655\" data-linked=\"United Rentals made a top pick at BAML\" data-tweet=\"$URI - United Rentals made a top pick at BAML https://seekingalpha.com/news/3325655-united-rentals-made-top-pick-baml?source=tweet\" data-url=\"https://seekingalpha.com/news/3325655-united-rentals-made-top-pick-baml\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325654\" data-ts=\"1516970547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325654-kla-tencorminus-1_1-after-q2-report-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KLA-Tencor -1.1% after Q2 report with downside guidance</a></h4><ul><li>        KLA-Tencor (NASDAQ:<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a>) shares are&nbsp;<font color='red'>down 1.1%</font>&nbsp;premarket after reporting Q2 results yesterday aftermarket. The company beat revenue and EPS estimates.&nbsp;</li><li>        Q3 guidance: Revenue, $0.97B to $1.03B (consensus: $1.08B); EPS, $1.85 to $2.09 (consensus: $2.14); shipments, 945M to 1.025B; gross margin, 63.5% to 64.5%.</li><li>               FY18: Revenue, high single-digit growth; shipments, high single-digit growth; gross margin, 63% to 64%. &nbsp;&nbsp;</li><li>               Q2 results: Shipments, $977M; cash and investments, $2.7B; accounts receivable, $735M; net DSO (shipment), 74 days; inventories, $697M; inventory turns, 2x; cash from operating activities, $225M; capital expenditures, $9M; FCF, $215M; total liabilities, $4.2B.&nbsp;</li><li>               Shipments by segment (percentile): Wafer inspection, 46%; Patterning, 30%; Service, 21%; Non-Semi, 3%.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17057089-kla-tencor-reports-fiscal-2018-second-quarter-results\" target=\"_blank\">Press release</a> / <a href=\"http://ir.kla-tencor.com/static-files/4dc615cb-35e6-4893-8292-44a3ea1329b5\" target=\"_blank\">Presentation</a>&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325481-kla-tencor-beats-0_24-beats-revenue\" target=\"_blank\">KLA-Tencor beats by $0.24, beats on revenue</a> (Jan. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3325654\" data-linked=\"KLA-Tencor -1.1% after Q2 report with downside guidance\" data-tweet=\"$KLAC - KLA-Tencor -1.1% after Q2 report with downside guidance https://seekingalpha.com/news/3325654-kla-tencorminus-1_1-after-q2-report-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3325654-kla-tencorminus-1_1-after-q2-report-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325646\" data-ts=\"1516969052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CL\" target=\"_blank\">CL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325646-pricing-nips-colgate-palmolives-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pricing nips at Colgate-Palmolive&#39;s margins</a></h4><ul> <li>Colgate-Palmolive (NYSE:<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a>) reports organic sales increased 2.0% in Q4 to miss the consensus estimate for a 2.9% rise. Organic sales in North America were up 1%, while Asia Pacific organic sales increased 2.5%.</li> <li>Global unit volume was up 3.0% during the quarter, while pricing decreased 1.0%. The company saw a positive benefit from F/X swings of 2.5 percentage points.</li> <li>Gross margin arrived at 60.4% of sales vs. 60.8% a year ago and 61.0% consensus. Higher raw and packaging material costs and lower pricing nipped at margins.</li> <li>SG&amp;A expenses wee 35.3% of sales vs. 33.7% a year ago.</li> <li>Operating profit margin fell 190 bps to 26.0% of sales.</li> <li>Looking ahead, Colgate-Palmolive expects category growth this year to be \"challenging\" but sees a reduction in its effective tax rate to 26% to 27%.</li> <li>Shares of Colgate-Palmolive are <font color='red'>down 2.99%</font> in premarket action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325634-colgate-palmolive-eps-line-misses-revenue\" target=\"_blank\">Colgate-Palmolive EPS in-line, misses on revenue</a> (Jan. 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325646\" data-linked=\"Pricing nips at Colgate-Palmolive&#39;s margins\" data-tweet=\"$CL - Pricing nips at Colgate-Palmolive&#39;s margins https://seekingalpha.com/news/3325646-pricing-nips-colgate-palmolives-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3325646-pricing-nips-colgate-palmolives-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325644\" data-ts=\"1516968769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325644-astrazenecas-pt010-successful-in-late-stage-copd-study-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca&#39;s PT010 successful in late-stage COPD study; shares up 1% premarket</a></h4><ul><li>AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on average volume on the heels of its <a href=\"https://www.astrazeneca.com/media-centre/press-releases/2018/astrazeneca-reports-top-line-phase-iii-kronos-trial-results-for-pt010-triple-combination-therapy-in-chronic-obstructive-pulmonary-disease-26102018.html\" target=\"_blank\">announcement </a>of positive results from a Phase 3 clinical trial, KRONOS, evaluating triplet therapy PT010 in patients chronic obstructive pulmonary disease &#40;COPD&#41; over a 24-week treatment period.</li><li>Results showed PT010 achieved eight out of nine lung function primary endpoints based on forced expiratory volume in one second (FEV1) measurements in patients with moderate-to-very severe COPD.</li><li>KRONOS compared PT010 (budesonide/glycopyrronium/formarate 320/14.4/9.5&micro;g) to Bevespi Aerosphere (glycopyrronium/formoterol fumarate 14.4/9.6&micro;g), Symbicort Turbohaler (budesonide/formoterol fumarate 400/12&micro;g) and PT009 (budesonide/formoterol fumarate 320/9.6&micro;g). Participants received two inhalations twice a day.</li><li>Detailed results will be submitted for presentation at an upcoming medical conference. Regulatory submissions in Japan and China should be filed in H2, followed by applications in the U.S. and Europe in 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325644\" data-linked=\"AstraZeneca&#39;s PT010 successful in late-stage COPD study; shares up 1% premarket\" data-tweet=\"$AZN - AstraZeneca&#39;s PT010 successful in late-stage COPD study; shares up 1% premarket https://seekingalpha.com/news/3325644-astrazenecas-pt010-successful-in-late-stage-copd-study-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3325644-astrazenecas-pt010-successful-in-late-stage-copd-study-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325643\" data-ts=\"1516968387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325643-bed-bath-beyond-lower-after-jpmorgan-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond lower after JPMorgan cut</a></h4><ul> <li>Shares of Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) are on watch after JPMorgan <a href=\"https://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+Bed+Bath+%26+Beyond+%28BBBY%29+to+Underweight/13726257.html\" target=\"_blank\">lowers</a> its rating to Underweight from Neutral.</li> <li>JP warns on increased comeptition in the home furnishing space and thinks estimates on tax reform savings may be overstated.</li> <li>The firm's lowered price target of $18 reps 22% downside potential on BBBY from yesterday's closing price.</li> <li>Shares of Bed Bath &amp; Beyond are <font color='red'>down 4.47%</font> in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3325643\" data-linked=\"Bed Bath &amp; Beyond lower after JPMorgan cut\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond lower after JPMorgan cut https://seekingalpha.com/news/3325643-bed-bath-beyond-lower-after-jpmorgan-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3325643-bed-bath-beyond-lower-after-jpmorgan-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3325630\" data-ts=\"1516967540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3325630-biocept-prices-equity-offering-0_45-shares-down-19-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept prices equity offering at $0.45; shares down 19% premarket</a></h4><ul><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) is down&nbsp;<font color='red'>19%</font>&nbsp;premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/17057369-biocept-announces-pricing-15_0-million-public-offering-33333-333-shares-common-stock-warrants\" target=\"_blank\">public offering </a>of common stock and warrants at a combined price of $0.45. Specifically, the offering is 33,333,333 shares of stock and accompanying five-year warrants to purchase up to 33,333,333 shares of common at $0.50.</li><li>Gross proceeds should be ~$15M. Closing date is January 30.</li><li>Yesterday's close was $0.48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3325630\" data-linked=\"Biocept prices equity offering at $0.45; shares down 19% premarket\" data-tweet=\"$BIOC - Biocept prices equity offering at $0.45; shares down 19% premarket https://seekingalpha.com/news/3325630-biocept-prices-equity-offering-0_45-shares-down-19-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3325630-biocept-prices-equity-offering-0_45-shares-down-19-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":72,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}